We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Synthesis and Biological Evaluation of 1,2,3-Triazole Tethered Thymol-1,3,4-Oxadiazole Derivatives as Anticancer and Antimicrobial Agents.
- Authors
Almalki, Abdulraheem S. A.; Nazreen, Syed; Malebari, Azizah M.; Ali, Nada M.; Elhenawy, Ahmed A.; Alghamdi, Abdullah A. A.; Ahmad, Abrar; Alfaifi, Sulaiman Y. M.; Alsharif, Meshari A.; Alam, Mohammad Mahboob
- Abstract
A library of 1,2,3-triazole-incorporated thymol-1,3,4-oxadiazole derivatives (6–18) hasbeen synthesized and tested for anticancer and antimicrobial activities. Compounds 7, 8, 9, 10, and 11 exhibited significant antiproliferative activity. Among these active derivatives, compound 2-(4-((5-((2-isopropyl-5-methylphenoxy)methyl)-1,3,4-oxadiazol-2-ylthio)methyl)-1H-1,2,3-triazol-1-yl)phenol (9) was the best compound against all three tested cell lines, MCF-7 (IC50 1.1 μM), HCT-116 (IC50 2.6 μM), and HepG2 (IC50 1.4 μM). Compound 9 was found to be better than the standard drugs, doxorubicin and 5-fluorouracil. These compounds showed anticancer activity through thymidylate synthase inhibition as they displayed significant TS inhibitory activity with IC50 in the range 1.95–4.24 μM, whereas the standard drug, Pemetrexed, showed IC50 7.26 μM. The antimicrobial results showed that some of the compounds (6, 7, 9, 16, and 17) exhibited good inhibition on Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus). The molecular docking and simulation studies supported the anticancer and antimicrobial data. It can be concluded that the synthesized 1,2,3-triazole tethered thymol-1,3,4-oxadiazole conjugates have both antiproliferative and antimicrobial potential.
- Subjects
BIOSYNTHESIS; ANTI-infective agents; ANTINEOPLASTIC agents; THIADIAZOLES; THYMIDYLATE synthase; DRUG standards
- Publication
Pharmaceuticals (14248247), 2021, Vol 14, Issue 9, p866
- ISSN
1424-8247
- Publication type
Article
- DOI
10.3390/ph14090866